ϩ -ATPase in macrophage. We conducted this investigation on Langendorff perfused hearts of rabbits to elucidate the mechanisms involving the NO · precursor L-arginine on myocardial contractile function, glycolysis, mitochondrial respiration, and intracellular alkalinization and tested the effects of amiloride. L-Arginine caused a significant loss of contractile function (96Ϯ4 mmHg in control, 53Ϯ16 during L-arginine perfusion, pϽ0.01) and a significant increase of pH i (7.01Ϯ0.02 prearginine infusion, 7.08Ϯ0.03 at the end of L-arginine infusion, pϽ0.01) along with decreased oxygen consumption (MVO 2 ) (0.94Ϯ0.32 ml/min/g dry wt.), increased lactate release, and a loss of creatine phosphate (15% loss). Amiloride could prevent the cell alkalinization and contractile dysfunction, but not the derangement of oxidative metabolism caused by L-arginine in myocytes. We conclude that L-arginine has two distinct effects upon the myocardium: (1) an amiloride-sensitive loss of contractile function associated with intracellular alkalinization; and (2) an amilorideinsensitive inhibition of oxidative metabolism, possibly because of increased myocardial NO · production. [Japanese Journal of Physiology, 52, 207-215, 2002] tion and intracellular alkalinization (0.08 pH unit rise) via the activation of Na ϩ /H ϩ exchanger [5] . Moolenaar and his associates [6] have suggested that alkaline pH i shift, mediated by Na ϩ /H ϩ antiport, may be a common signal in the action of a platelet-derived growth factor that elicits the breakdown of inositol phospholipids. To further elucidate these mechanisms of injury in myocardium, we studied the effects of Larginine, which may be associated with NO production, and tested the effects of amiloride, which is a Na ϩ /H ϩ exchange inhibitor on myocardial contractility, oxidative metabolism, glycolysis, and intracellular pH in an isolated Langendorff-perfused rabbit heart.
METHODS
Experimental preparation. Animal procedures received institutional approval and were conducted in conformity with the "Guiding Principles in the Care and Use of Animals" of the American Physiology Society and the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (NIH publication No. 85-23, revised, 1985) . New Zealand white rabbits (3-4 kg) were anesthetized with ketamine hydrochloride (50 mg/kg) and heparinized with 1,000 U of heparin. The hearts were excised and perfused in crystalloid Langendorff perfusion mode with 80 mmHg pressure constant at 37°C. The composition of Krebs-Henseleit buffer (in mmol/l) was NaCl, 140; CaCl 2 , 1.25; KCl, 4.7; glucose, 11.0; MgSO 4 , 1.2; NaHCO 3 , 25; and NaH 2 PO 4 , 0.5. Bovine regular insulin, 10 U/l, was also included. Hearts were then rapidly perfused retrograde through the aorta in the Langendorff mode at 80 mmHg constant pressure with 37°C buffer that had been equilibrated with a 95% O 2 -5% CO 2 gas mixture and passed through a 0.2 m filter. The final buffer pH was 7.35-7.45, PO 2 was 500-600 mmHg, and PCO 2 was 30-40 mmHg. The hearts were enclosed in a water-jacketed chamber; myocardial temperature was monitored continuously with a thermistor placed in the right ventricle and maintained at 36-37°C. The pulmonary outflow tract was incised and cannulated to collect a coronary effluent. A latex fluid-filled balloon connected to a micromanometry catheter (Miller Instruments, Co., Houston, TX) was adopted for isovolumic left ventricular function measurements. The balloon was inserted into the left ventricle, sewn to the mitral annulus to prevent herniation, and balloon volume was varied with a calibrated fluid-filled syringe. Oxygen consumption of the heart was determined by measuring the oxygen tension of the perfusate and coronary effluent, and coronary flow was measured by a timed coronary effluent collection.
Oxygen consumption, glucose uptake, and lactate release. The myocardial oxygen consumption (MVO 2 ) was derived from the difference of O 2 tension between the aortic perfusate and coronary effluent (ABL-3 Acid-Base Laboratory, Radiometer, Copenhagen, Denmark) and the coronary flow rate. Lactate and glucose levels were measured by enzymatic assay (model 2,300 STAT, YSI, Yellow Springs, OH). Glucose uptake was determined by the differences of glucose concentration between aortic perfusate and coronary effluent and coronary flow. The lactate level was determined by the calculation of coronary flowϫlactate (mol/min/g dry wt.).
Experimental protocol. All chemicals were purchased from Sigma (St. Louis, MO). After an initial 30 min stabilization period with normal buffer, preinfusion contractile function and metabolic parameters were determined. Two experimental groups were studied. In the first (nϭ6), L-arginine (2.5 mmol/l, pHϭ10 in stock solution) was infused for 2 min and 40 s followed by 30 min of washout with functional and metabolic parameters being measured continuously (L-arg group). In the second group of hearts (nϭ6), 30 mol/l amiloride was infused for 5 min before and during arginine infusion as well as during the washout period (Amilo group). The developed pressure (DevP) and end-diastolic pressure (EDP) by intracavitary balloon and MVO 2 , glucose uptake, and lactate production were evaluated.
To evaluate the effects of other basic amino acids, such as L-lysin and D-arginine, using stock solutions of Krebs-Henseleit (K-H) buffer with pH being adjusted at 10, we infused the stock solution of K-H buffer containing 2.5 mmol/l L-lysin (L-lys, pHϭ10) or 2.5 mmol/l D-arginine (D-arg, pHϭ10) for 2 min and 40 s; we then perfused those hearts for another 30 min with normal buffer in the K-H, L-lys, and Darg groups (nϭ5, each). The purpose of the experiment, where pH-adjusted K-H buffer stock solution was infused, was to test if alkaline stock solution (pH 10) may affect myocardial function and/or metabolism in a Langendorff-perfused heart. Intracellular pH was measured by 31 P-NMR spectroscopy in L-arg, Amilo, and L-lys groups by the use of other sets of hearts.
Furthermore, another 3 groups of hearts (nϭ5) were used to determine lactate and glucose level in the myocardium infused with L-arginine alone, amilorideϩL-arginine, or vehicle. Heart tissues were excised and quickly frozen in liquid nitrogen, then prepared for the measurements via the method described by Williamson et al. [7] .
NMR spectroscopy. Another 17 hearts were used for the NMR spectroscopy measurements of the L-arg group (n=6), the Amilo group (nϭ6), and the Llys group (nϭ5). Isovolumic rabbit hearts were perfused in the Langendorff mode with a modified phosphate-free K-H buffer containing 1.8 mM CaCl 2 and 11 mmol/l glucose. A bulb containing dimethylene phosphonic acid (DMPA) as an internal standard was placed in the right ventricle, and the right atrium was sutured closed. All experiments were performed in a 40 cm horizontal-bore, 4.7 T Brucker BioSpec spectrometer (Brucker Instruments, Inc., Billerica, MA) operating at the 31 P frequency of 81 MHz. A 90°ra-diofrequency pulse was applied with a recycle time of 1 s and an acquisition time of 81 ms during a period of 2 min and 40 s for a total of 148 acquisitions per spectrum. Intracellular pH was determined by the following equation [8] : pHϭ6.75ϩlog(ѨϪ3.37/5.69ϪѨ), where Ѩ is the chemical shift difference in parts per million between Pi and phosphocreatine (PCr). Concentration measurements of each of the phosphoruscontaining metabolites were estimated by an integration of the area under the individual peaks. PCr and ATP levels were expressed as a percent of the preinfusion area.
Statistical analysis. Results were expressed by meanϮstandard errors of the means (SEM) of the number of experiments indicated in parentheses. The data were analyzed by the use of the analysis of variance (ANOVA) with repeated measures when appropriate. Differences between specific means were tested by post hoc analysis that applied Student's t-test with a Bonferroni correction.
RESULTS

Mechanical, metabolic, and energetic effects of D-arginine, L-arginine, L-lysin, and NaOH
DevP, end-diastolic pressure (EDP), coronary flow, MVO 2 , and pH i data obtained from Langendorff-perfused rabbit hearts are shown in Table 1 . To exam the alkaline pH effect of stock solution, we prepared and tested the stock solution of K-H buffer with pH being adjusted at 10. An insignificant change of myocardial function was attained by the infusion of pH-adjusted stock solution (pHϭ10). It was 99Ϯ1 mmHg of DevP and 6.8Ϯ0.5 mmHg of EDP at the end of infusion.
In L-lys group, DevP was remarkably decreased after the infusion. It was decreased from 101Ϯ8 to 30Ϯ8 mmHg at the end of the infusion. Coronary flow was markedly decreased (73Ϯ2 ml/min/g dry wt. vs. 9Ϯ5 ml/min/g dry wt. at the end of the infusion) in Llys group, whereas it was only 50% decreased in the L-arg group. Although the pH i was significantly increased immediately after the onset of infusion in the L-arg group, there was no significant increase of pH i in the L-lys group. Phosphocreatine was 94Ϯ2% of control, whereas Pi was 164Ϯ33% of control during the infusion of L-lysin.
In the D-arg group, myocardial function was decreased in association with a decrease of coronary flow (6Ϯ1 ml/min/g dry wt. during infusion vs. 59Ϯ5 ml/min/g dry wt. pre-infusion). pH i was decreased after the infusion of D-arginine in association with a decrease of PCr by 28Ϯ5% of control and a contrary increase of Pi by 200Ϯ91% of control.
Cardiac function
Systolic pressure increased in the initial phase of Larginine infusion, and EDP increased (data are not shown in the table). After about 1 min, DevP decreased to 54% of pre-L-arginine infusion (96Ϯ4 mmHg vs. 52Ϯ15 mmHg at the end of L-arginine infusion, pϽ0.01) (Fig. 1a) . Systolic and diastolic pressures were gradually restored to the baseline during the washout of L-arginine (Figs. 2, 3) . Preloading with amiloride provided no significant changes of hemodynamics. An increase of systolic pressure during the early L-arginine infusion was not prevented with 30 mol/l amiloride (Figs. 1b, 2) . The functional deterioration of developed pressure caused by L-arginine Cell Alkalinization Induced by L-Arginine was completely prevented (Fig. 2) , whereas EDP was significantly higher in the Amilo group during the infusion period and washout period (Fig. 3 ). This may be related to a higher cytosolic calcium concentration in the Amilo group.
Oxygen consumption (MVO 2 )
No significant difference was noted between the Larg group and the Amilo group in MVO 2 before the Larginine infusion. MVO 2 significantly decreased by the end of the arginine infusion (1.80Ϯ0.05 ml/min/g dry wt. vs. 0.94Ϯ0.29 ml/min/g dry wt., pϽ0.01) (Fig. 4) and was gradually recovered by 30 min of washout in the L-arg group. It was quite constant in the Amilo group, however, this was significantly different from the L-arg group during the infusion and early washout period (1.59Ϯ0.15 ml/min/g dry wt. at the end of the infusion).
L-Arginine effect on intracellular pH
A significant increase of intracellular pH occurred, to 7.08Ϯ0.03 pH units, from 7.01Ϯ0.02 ( pϽ0.01), by 2.5 mmol/l L-arginine infusion, showing a cytosolic alkalinization by L-arginine. And the pH i then rapidly declined to 6.87Ϯ.03 pH units during the early washout period, with a gradual recovery of pH units within 30 min of washout (Fig. 5) . In the presence of amiloride, however, pH i did not significantly increase nine infusion or decrease during the washout period (Fig. 5) (pϾ0.05) .
High-energy phosphates and inorganic phosphates
In the L-arginine treated hearts, a significant decline in PCr (15% loss) and a significant increase of Pi (57% increase) (Table 2) were noted, followed by the complete recovery of PCr and Pi after 5 min of washout. It is possible to say that a 57% increase of Pi is almost equivalent to the 15% loss of PCr in terms of moles. Although amiloride prevented intracellular alkalinization and loss of contractile function, it did not prevent the decline of PCr with the reciprocal increase of Pi during arginine infusion. A 16% loss of PCr level and a 39% increase of Pi level were seen in the Amilo group (Table 2 ). In contrast, the ATP level was nearly constant in the L-arg and Amilo groups. These data suggested that L-arginine could affect the high-energy phosphate potential and that amiloride did not improve this energetic insult.
Lactate production
L-Arginine caused a gradual increase of lactate release during the infusion (6.9Ϯ2.7 mol/min/g dry wt.) as well as early washout (9.6Ϯ7.2 mol/min/g dry wt.). In contrast, in the presence of amiloride a markedly augmented release of lactate was observed during the L-arginine infusion (29Ϯ4.7 mol/min/g dry wt.). This lactate level rapidly returned to baseline during early washout (2.4Ϯ0.9 mol/min/g dry wt.) ( Table 3 ). The myocardial tissue lactate level was also Cell Alkalinization Induced by L-Arginine significantly higher in the Amilo group (3.6Ϯ0.5 g/g dry wt.) than in the L-arg group (2.1Ϯ0.3 mol/min/g dry wt.) at the end of the L-arginine infusion (Table  3) .
Glucose uptake and tissue glucose
Glucose uptake did not significantly change in the L-arg group, whereas a significant increase was seen in the Amilo group at the end of the infusion (Table  3) . Tissue glucose level was significantly higher in the L-arg group (16.9Ϯ1.9 mol/g dry wt.) than in the other groups, such as the K-H group (11.5Ϯ0.6 mol/g dry wt., pϽ0.01 vs. L-arg group) and the Amilo group (7.8Ϯ0.4 mol/g dry wt., pϽ0.01 vs. Larg and K-H groups).
DISCUSSION
The effect of L-arginine was unique on pH i and energy metabolism. L-Arginine has an action of intracellular alkalinization as a result of the activation of an amiloride-sensitive Na NO · will rapidly diffuse both within the endothelial cells and across the plasma membrane to nearby cells [23] and induce a rise in the concentration of cGMP [24, 25] mediated by guanylyl cyclase that results in smooth muscle relaxation. NO · released from endocardial cells by the Ca 2ϩ -dependent NO · synthetase [26] plays a role in the physiological modulation of myocardial contractility by increasing the level of cyclic GMP in cardiac muscle, and this exerts a negative inotropic effect [15, 27] . This action is thought to be a possible mechanism that explains how NO · is effective to protect ischemia/reperfusion injury [28] [29] [30] . Swallow et al. [5] suggested that nitroprusside caused a rapid inhibition of intracellular pH homeostasis in association with a marked increase of cGMP levels, and the incubation of macrophages with the membrane-permeant form of cGMP, 8-bromo cGMP, impaired H ϩ -ATPase-mediated intracellular pH regulation. The activation of a cGMP-dependent kinase appears to be a signal transduction pathway in other cell types [28, [31] [32] [33] [34] . Furthermore, Semrad and his associates [35] have shown that 8-bromo cGMP inhibits Na ϩ /H ϩ exchange in chicken enterocytes, resulting in cytoplasmic acidification. cGMP increased by nitroprusside-reduced lactate accumulation in hypoxic rat myocardium was also reported [36] .
Another plausible mechanism of cell alkalinization is that the influx of Ca 2ϩ through the Na 
/H
ϩ antiport, may be a common signal in the action of platelet-derived growth factor that elicits the breakdown of inositol phospholipids. Phosphoinositide cascade evokes a wide variety of responses in many kinds of cells, such as glycogenolysis in liver cells and smooth muscle contraction [36] . The intracellular messenger formed by the activation of this pathway arises from phosphatidyl inositol 4,5-bisphosphate (PIP2), a phospholipid in the plasma membrane. The binding of a hormone such as serotonin to a cell surface receptor leads to the activation of phosphoinositidase (phospholipase C). Two messengers, inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG), are formed by the cleavage of PIP2. Submicromolar levels of IP3 mobilize Ca 2ϩ from intracellular stores by directly opening Ca channels in the membrane of the endoplasmic reticulum and the sarcoplasmic retic-ulum. So an increase in [Ca 2ϩ ] i promotes Na ϩ accumulation via the Na ϩ /H ϩ antiport, leading to the observed decrease in intracellular H ϩ (intracellular alkalinization). Although we did not determine the [Ca 2ϩ ] i level, our data showing an increase of systolic pressure followed by an increase of end-diastolic pressure may imply an increase of [Ca 2ϩ ] i influx (Fig. 1) This study also supports the hypothesis that myocardial cells treated with L-arginine exhibited the inhibition of the mitochondrial respiratory chain because MVO 2 rapidly decreased with L-arginine administration to 52%, accompanying the decrease of the contractile function. This phenomenon is also accompanied by an increased lactate production, which indicated the inhibition of oxidative phosphorylation and the acceleration of anaerobic glycolysis. At the end of L-arginine infusion, the rate of lactate release into the coronary effluent had increased to 6.9Ϯ2.7 (mol/min/g dry wt.) and the tissue lactate also significantly increased, suggesting the stimulation of anaerobic glycolysis. Although the ATP level stayed nearly constant, PCr was decreased by 15% because of the anaerobic condition where glycolysis was the only pathway for energy production. Anaerobic glycolysis is less effective (only 2 ATP molecules) than that from the aerobic glucose combustion (36 ATP molecules). Geng and his associates [38] reported that INF-␥ϩTNF-␣ promote anaerobic glycolysis via the L-arginine-NO · pathway in isolated vascular smooth muscle cells.
L-Arginine caused a temporal inhibition of mitochondrial respiration. One possible mechanism of inhibition of the mitochondrial respiratory system by Larginine might be NO ·-mediated injury, since the NO · mediated inhibition of mitochondrial respiration was reported in activated macrophages [3, 38, 39] and isolated rat pancreatic islets [40] . NO · readily forms complexes with the transition metal iron, nonheme transition metal complex, as well as heme-containing proteins, such as hemoglobin [40] and myoglobin [41] . Its reactivity toward iron-sulfur centers in proteins, which are in complex I and complex II in the mitochondrial electron transport system, and/or aconitase in TCA cycle [38, 39, 42] , might be especially important for the NO ·-dependent inhibition of myocardial respiration and glucose oxidation. This is supported by data revealing that reconstitution of the iron-sulfur complex restores aconitase activity in NO ·-exposed tumor cells [43] . However, we could detect no increase of NO · related products by L-arginine infusion in coronary effluent by HPLC or myocardium by EPR. The crystalloid perfusion system may be an explanation for nondetectable NO ·-related products. Because of no significant change of the nitrosocompound signal in myocardium measured by EPR, the NO ·-dependent pathway may not be involved in this mechanism of mitochondrial respiratory inhibition.
Amiloride, an aminoguanidine derivative, prevented the deterioration of oxygen consumption by L-arginine and attained good cardiac contractility (129Ϯ 5 mmHg in the Amilo group vs. 53Ϯ16 mmHg in the L-arg group). However, the PCr level decreased (16% loss). The NO ·-dependent inhibition of energy production pathway, most likely in the TCA cycle [42, 44, 45] , might not be protected by amiloride. Regarding glucose and lactate metabolism, total lactate production, i.e., lactate release and tissue lactate level, was significantly higher in the Amilo group than in the L-arg group. Glucose metabolism was also augmented in amiloride-treated heart, suggesting a promotion of anaerobic glycolysis by amiloride. This might be a potential benefit that will help to maintain better myocardial function. This lactate accumulation may also be associated with the protection of cell alkalinization attained by L-arginine.
In summary, we studied the effects of a basic semiessential amino acid, L-arginine, on cardiac function, myocardial metabolism, and intracellular alkalinization by using crystalloid perfused rabbit hearts in a Langendorff mode. Our data suggest that L-arginine has two distinct effects on the myocardium: (1) a novel, amiloride-reversible (Na ϩ /H ϩ antiport mediated) loss of contractile function associated with intracellular alkalinization; and (2) an amiloride-insensitive inhibition of oxidative metabolism, possibly because of increased myocardial NO · production. Since NO was not detected in coronary effluent or tissue, however, the mechanism of myocardial injury by Larginine may be something else. Further studies may add even more insight into this mechanism.
